CH1125843347 - SOPH - A3CVT8 (XNAS)
SOPHIA GENETICS SF -,05 Acción
3,03 EUR
Cotizaciones actuales de SOPHIA GENETICS SF -,05
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria | Variación diaria % |
---|---|---|---|---|---|---|
NASDAQ |
SOPH
|
USD
|
20.12.2024 21:13
|
3,16 USD
| 3,06 USD | 3,28 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,70 % | -2,30 % | 0,86 % | -14,18 % | -31,36 % | -24,17 % | -79,98 % |
Company Profile for SOPHIA GENETICS SF -,05 Share
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Company Data for SOPHIA GENETICS SF -,05 Share
Name SOPHIA GENETICS SF -,05
Company SOPHiA GENETICS SA
Symbol SOPH
Website https://www.sophiagenetics.com
Primary Exchange
Frankfurt
WKN A3CVT8
ISIN CH1125843347
Asset Class Share
Sector Healthcare
Industry Medical - Healthcare Information Services
CEO Dr. Jurgi Camblong M.B.A., Ph.D.
Market Capitalization 251 Mio
Country Switzerland
Currency EUR
Employees 0,4 T
Address Rue du Centre 172, 1025 Saint-Sulpice
IPO Date 2021-07-23
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | 90B.F |
NASDAQ | SOPH |
More Shares
Investors who SOPHIA GENETICS SF -,05 hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.